Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
| Autor: | Grinsztejn, Beatriz, Nguyen, Bach-Yen *, Katlama, Christine, Gatell, Jose M, Lazzarin, Adriano, Vittecoq, Daniel, Gonzalez, Charles J, Chen, Joshua, Harvey, Charlotte M, Isaacs, Robin D |
|---|---|
| Zdroj: | In The Lancet 14-20 April 2007 369(9569):1261-1269 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|